TO THE EDITOR
Since the introduction of cytogenetic analyses into the study of plasma cell neoplasias, it has been repeatedly shown that multiple myeloma (MM) is a heterogeneous disease with regard to the underlying chromosomal abnormalities. In a very recent issue of Leukemia, Debes-Marun et al 1 applied statistical cluster analyses towards the abnormal karyotypes of 254 myelomas from the Mayo Clinic (Rochester, MN, USA). By this novel approach, they were able to identify recurrent patterns of chromosomal changes and to define cytogenetic subgroups of the disease.
We recently analyzed the karyotypes of 276 cases of MM from European institutions with statistical methods similar to those applied by Debes-Marun et al. 1 In all, 138 karyotypes (including 72 published in Calasanz et al 2 ) were retrieved from the cytogenetic database of the Department of Genetics in Pamplona (Spain). Moreover, 138 karyotypes from another published European series 3 were included. The population studied by us is, thus, completely independent of the series studied by Debes-Marun et al, 1 and therefore constitutes a proper statistical validation set. Only MM with abnormal karyotypes were considered and those patients with a diagnosis of a secondary neoplasia were excluded. The presence or absence of chromosomal aberrations was recorded in all cases. A total of 30 recurrent cytogenetic variables present in more than 5% of the cases entered the statistical analyses, from which at least one was present in 250 cases.
Due to the nature of the variables, average linkage hierarchical clustering with three methods for computing distances, that is, Jaccard's, Dice's and Sokal's coefficients, were performed using the Stata, Clustan and SPSS software packages. The cluster trees derived from the three approximations were closely related (data not shown). Thus, from the statistical point of view, the methods applied in the present study and by Debes-Marun et al, 1 who used Jaccard's an Kendall's tau coefficients, are completely comparable.
Our results (Figure 1a ) are in excellent concordance with those published by Debes-Marun et al. 1 One cluster was characterized by hypodiploidy and included complete or partial losses of chromosomes X, 1, 2, 4, 5, 6, 8, 11, 13, 14, 16, 17, 20, 21 and 22. This cytogenetic cluster, besides the losses of chromosome 13 (51/76 cases in this cluster), also contained structural abnormalities in 14q32 (19/76 cases in this cluster) and 22q (29/76 cases in this cluster), suggestive for translocations involving the immunoglobulin genes, IGH and IGL, respectively. Translocations involving IGH might also be hidden in the cases with monosomy 14 (32/76 cases in this cluster), which may indicate the loss of the der(14) from a cryptic IGH translocation as has been reported to be recurrent in t(4;14)(p16;q32). 4 A second major cytogenetic branch was characterized by a hyperdiploid karyotype due to multiple trisomies (gains or partial gains of chromosomes 3, 5, 7, 9, 11, 15, 19 and 21). The 95 cases assigned to this cytogenetic cluster only rarely contained breakpoints in 14q32 (9/95 cases). The incidence of cytogenetic 14q32 breakpoints and monosomy 13 in the hyperdiploid subgroup was significantly lower than in the hypodiploid cluster (9/95 vs 19/76, P ¼ 0.006 and 19/95 vs 51/ 76, Po0.001, respectively, by Fisher's exact test). Moreover, the frequency of appearance of monosomy 14 and 22q abnormalities, suggesting the presence of IG rearrangements, was also significantly lower in the hyperdiploid branch (8/95 vs 32/76, Po0.001 and 7/95 vs 29/76, Po0.001, respectively). A third major cytogenetic branch was characterized predominantly by structural aberrations in 14q32, but wide lack of a considerable number of chromosomal losses. Out of 49 MM assigned to this cluster, 37 carried 14q32 aberrations.
Thus, clustering of cytogenetic abnormalities in MM reveals two clusters with frequent IG translocations with and without marked hypodiploidy as well as a distinct hyperdiploid cluster. In addition, minor cytogenetic clusters might exist, such as MM with duplications in 1q or loss of the Y chromosome. Nevertheless, the biological meaning of these minor clusters warrants further investigations.
Whereas it can be assumed that IG-driven oncogene activation is the major underlying genetic change in the nonhyperdiploid clusters, the genetic basis of the hyperdiploid MM group is widely unknown. Besides the rarity of recurrent translocations, this group is characterized by trisomies of mostly structurally intact chromosomes as well as a comparably favorable prognosis. [3] [4] [5] Remarkably, another lymphocyte- 
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Continued Correspondence derived neoplasia is characterized by the very same features, namely, hyperdiploid acute lymphoblastic leukemia (ALL) with more than 50 chromosomes. 6 This subtype of ALL, also recognized as a distinct entity by the WHO classification of hematologic neoplasia, 7 comprises approximately 20-25% of ALL and displays a characteristic gene expression profile. 8 It is intriguing to speculate that hyperdiploid MM and ALL may have in common a similar pathogenic mechanisms leading to the multiple chromosomal trisomies.
In order to compare the pattern of chromosomal gains between the hyperdiploid variants of MM and ALL, we performed clustering of karyotypes from these neoplasms. Based on the definition of hyperdiploid ALL by the WHO classification, 7 only those tumors entered this analysis, which contained more than 50 chromosomes (chromosomal gains defined by the presence of the respective centromere) and lacked any typical structural aberration like breakpoints in IG loci in MM or t(9;22)(q34;q11.2), 11q23 (MLL) rearrangements, t(1;19) (q23;p13.3) or t(12;21)(p13;q22) in ALL. Karyotypes from 23 hyperdiploid ALL with more than 50 chromosomes retrieved from the databases of the Department of Genetics in Pamplona and the Institute of Human Genetics in Kiel were compared to the 51 MM cases from the above-described hyperdiploid myeloma cluster fulfilling the inclusion criteria. Average linkage hierarchical clustering of the trisomies using Jaccard's coefficient resulted in a perfect differentiation between MM and ALL, (Figure 1b) . Hyperdiploid MM were characterized by gains of chromosomes 3, 5, 7, 9, 11, 15 and 19, whereas hyperdiploid ALL showed predominately trisomies of chromosomes X, 4, 6, 8, 10, 14, 17, 18, 21 and 22 (Figure 1b) . The different patterns of chromosomal aberrations in hyperdiploid MM and ALL suggest different but conserved mechanisms to underlie the occurrence of the trisomies in these disorders. Remarkably, the vast majority of chromosomes with frequent trisomies in ALL were recurrently lost in the hypodiploid chromosome cluster in MM. This might somehow suggest the existence of distinct sets of chromosomes with regard to chromosomal segregation.
In conclusion, the results presented here confirm in an independent series the presence of distinct cytogenetic clusters of MM described by Debes-Marun et al. The highly comparable results of the present and the published study, 1 which were obtained from independent MM series of more than 250 patients each from different continents, show the results to be valid. In the nonhyperdiploid subgroups of MM, the activation of oncogenes by IG translocations seems to be a major pathogenic mechanisms. Unfavorable prognostic factors like rearrangements in 14q32, monosomy 13, and 17p deletions and hypodiploidy [3] [4] [5] cluster together in the same subset of MM making it difficult to discern whether the unfavorable outcome is caused by one or by the conjunction of all these factors at the same time. The pathogenic mechanisms underlying hyperdiploid MM are hitherto unknown. Nevertheless, the distinct and widely nonoverlapping patterns of trisomies observed between MM and ALL patients suggest hyperdiploidy in both diseases to be caused by different but obviously nonrandom events, which might influence proper chromosome segregation in B-lymphocytes. The delineation of karyotypic patterns using statistical approaches provides a new perspective for studying cytogenetic variability and complexity in malignancies. Based on the statistical descriptions of cytogenetic evolution patterns, the hypothesis on the underlying cellular defects can be generated, which may warrant future experimental investigations. 
